Question to the HM Treasury:

To ask the Chancellor of the Exchequer, with reference to EIM21774 of the Employment Income Manual, what assessment he has made of the effectiveness of the tax exemption for employer-funded medical treatment; and what estimate he has made of the (a) cost to the public purse of implementing that exemption, (b) savings accrued to the public purse of the use of that exemption and (c) amount that has been claimed by employers under that exemption since its introduction.

Employers normally incur expenditure on employee healthcare for a business purpose and can deduct this when calculating the employer’s own taxable profits.

However, from 1 January 2015, the Government also exempted any benefit in kind or payment of earnings, up to an annual cap of £500 per employee, from a charge to income tax when an employer meets the cost of recommended medical treatment. There is also a corresponding National Insurance contributions disregard.

Medical treatment is recommended where it is provided in accordance with a recommendation from an occupational health service in order to help an employee return to work after a period of absence due to ill-health or injury. The 28 consecutive day qualifying period makes sure that the tax exemption is targeted at those cases in greatest need of support. Evidence showed that sickness absence cases lasting four weeks or longer were at the greatest risk of turning into long term cases.

The Government ensured that this exemption would be easy to understand and administer, so employers do not need to inform HMRC about payments for treatments covered by the £500 per employee per year limit. This means that information is not available to assess the direct impact of the exemption. However, the Government estimated in 2014 that employees working for approximately 10,000 businesses each year would benefit and Table 2.2 of Budget 2014 set out the expected cost to the Exchequer of £20 million per annum by 2018-19.

The Government keeps all taxes under review.